Solid Tumors Clinical Trials in Cleveland, Ohio

7 studies are recruiting for solid tumors in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

    The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-u…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University Hospitals ( Site 0044), Cleveland, Ohio
    Locations
    782 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT03486873 on ClinicalTrials.gov

  2. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Investigative Site US050, Cleveland, Ohio
    Locations
    229 in total
    Run by
    Incyte Corporation

    See if you can join NCT07522073 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

    The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.

    Stage
    Phase 2
    Ages
    0 to 17
    Site
    University Hospitals Cleveland Medical Center, Cleveland, Ohio
    Locations
    5 in total
    Run by
    Spectrum Pharmaceuticals, Inc

    See if you can join NCT04570423 on ClinicalTrials.gov

  4. A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

    The purpose of this study is to evaluate the safety and tolerability of: * casdatifan when taken alone in participants with advanced solid tumor malignancies and clear cell renal cell carcinoma (ccRCC) during the dose escalation stage; and * casdatifan monotherapy and casdatifan in combination with…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, Cleveland, Ohio
    Locations
    25 in total
    Run by
    Arcus Biosciences, Inc.

    See if you can join NCT05536141 on ClinicalTrials.gov

  5. A Study of ZL-1310 in Participants With Selected Solid Tumors

    A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University Hospitals Cleveland Medical Center, Cleveland, Ohio
    Locations
    23 in total
    Run by
    Zai Lab (Shanghai) Co., Ltd.

    See if you can join NCT06885281 on ClinicalTrials.gov

  6. JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

    This study is to evaluate the efficacy and safety of JAB-30355 in adult participants with advanced solid tumors harboring TP53 Y220C mutation.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research site, Cleveland, Ohio
    Locations
    15 in total
    Run by
    Jacobio Pharmaceuticals Co., Ltd.

    See if you can join NCT06386146 on ClinicalTrials.gov

  7. ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

    This study is to assess the safety and antitumor activity of ABL103 plus pembrolizumab, with or without taxane, in advanced or metastatic solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UH Cleveland Medical Center, Cleveland, Ohio
    Locations
    6 in total
    Run by
    ABL Bio, Inc.

    See if you can join NCT07158918 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.